CEL SCI CEO buys 100K shares of stock at $1.38

CEL SCI CORP (CVM) reported that Chief Executive Officer and director Geert R. Kersten purchased 100,000 shares of restricted common stock directly from the company on August 25, 2026.

Rhea-AI Filing Summary

CEL SCI CORP (CVM) reported that Chief Executive Officer and director Geert R. Kersten purchased 100,000 shares of restricted common stock directly from the company on August 25, 2026. The shares were bought at $1.38 per share, equal to the August 24, 2026 closing price, according to a footnote.

Following this purchase, Kersten’s reported direct holdings increased to 316,142 shares of common stock. He also reports 311,547 shares of common stock held indirectly as Trustee, shown as a separate holding entry.

Insider Trade Summary

Net Buyer: 100,000 shares

Net Buy 2 txns

Insider KERSTEN GEERT R

Role Chief Executive Officer

Bought 100,000 shs ($138K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	100,000	$1.38	$138K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 316,142 shares (Direct); Common Stock — 311,547 shares (Indirect, Trustee)

Footnotes (1)

1. F1. On August 25, 2026, Mr. Kersten purchased 100,000 shares of restricted stock directly from the Company at the closing price on August 24, 2026, the most recent closing price available.

Key Figures

Shares purchased: 100,000 shares of common stock Purchase price per share: $1.38 per share Direct holdings after transaction: 316,142 shares +2 more

5 metrics

Shares purchased 100,000 shares of common stock Restricted stock purchased directly from the company on August 25, 2026

Purchase price per share $1.38 per share Equal to the August 24, 2026 closing price, per footnote F1

Direct holdings after transaction 316,142 shares Common stock held directly by Geert R. Kersten following the purchase

Indirect holdings as Trustee 311,547 shares Common stock reported as indirectly owned in Trustee capacity

Net buy shares 100,000 shares Net effect of reported buy and sell transactions in this filing

Key Terms

restricted stock, indirect, Trustee, Rule 10b5-1

4 terms

restricted stock financial

"purchased 100,000 shares of restricted stock directly from the Company"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

indirect financial

"ownership_type": "indirect", "ownership_code": "I""

Trustee financial

""nature_of_ownership": "Trustee""

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

Rule 10b5-1 regulatory

"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CVM CEO Geert R. Kersten report on August 25, 2026?

He reported purchasing 100,000 shares of CEL SCI CORP common stock as restricted stock on August 25, 2026, in a direct transaction with the company.

At what price did the CVM CEO buy the 100,000 CEL SCI shares?

The 100,000 restricted shares were purchased at $1.38 per share, which the footnote states was the closing price on August 24, 2026.

How many CEL SCI (CVM) shares does the CEO hold directly after this transaction?

After the reported purchase, Geert R. Kersten holds 316,142 shares of CEL SCI CORP common stock as direct ownership.

What indirect CEL SCI (CVM) holdings does the CEO report as Trustee?

He reports an additional 311,547 shares of CEL SCI CORP common stock held indirectly in a capacity described as Trustee.

Was the August 25, 2026 CVM insider purchase made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating the transaction was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 08:33 AM Accepted by SEC EDGAR 08/26/2026 - 08:32 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KERSTEN GEERT R

(Last) (First) (Middle)

8229 BOONE BLVD

STE 802

(Street)

VIENNA VIRGINIA 22182

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2026		P		100,000(1)	A	$1.38	316,142	D
Common Stock								311,547	I	Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On August 25, 2026, Mr. Kersten purchased 100,000 shares of restricted stock directly from the Company at the closing price on August 24, 2026, the most recent closing price available.

	Geert Kersten	08/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)